The Checkup by Singlecare

AUGUST 7, 2025

The generic form of Symbicort is budesonide-formoterol, which was launched in 2020 by the same manufacturer, AstraZeneca. This is called an authorized generic , meaning it is the exact same drug packaged without the brand name. Is there a generic for Symbicort? An authorized generic is usually marketed by the brand-name drug company.

Insurance

PharmTech

JUNE 23, 2025

From the Dilantin package insert: “The free acid form of phenytoin is used in DILANTIN-125 Suspension and DILANTIN Infatabs. BASF Opens GMP Manufacturing Facility in Michigan Susan Haigney June 19th 2025 Article The new facility offers cleanroom packaging and high-sensitivity analytical testing. Pharmaceutical Compounding Calculations.

Compounding

Pharmacy Times

JULY 15, 2025

What we've done is blend PillPack's innovative packaging with Amazon Pharmacy's user-friendly approach and affordability, so these patients can now get their medications in convenient, personalized packets and order everything online through our digital pharmacy.

Compounding Pharmacies

PharmTech

JUNE 12, 2025

. | Image Credit: © Tada Images - stock.adobe.com In a June 10, 2025 update, FDA posted seven updated Warning Letters, issued between the beginning of 2025 and the present, to its online database, which stores more than 3400 such letters dating back to 2020 (1).

FDA

Pharmaceutical Commerce

JULY 31, 2025

26 – Eli Lilly and Company announces that it will be constructing four new pharmaceutical manufacturing sites in the United States, representing financial commitments in the expansion space exceeding $50 billion since the start of 2020. It depends on what you're doing.”

Insurance

Pharmaceutical Technology

JULY 29, 2025

The drug was first approved by the EMA in September 2020 for use in RA. Jyseleca, a once-daily oral JAK1 preferential inhibitor, is already approved for the treatment of moderate to severe active rheumatoid arthritis (RA) and ulcerative colitis (UC). GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate?

Packaging

Pharmaceutical Technology

JUNE 19, 2025

Both modalities have emerged as the most used platform technologies in developing oligonucleotide-based drugs for CNS disorders since 2020. ASOs accounted for more than half ($3.54 billion), while siRNAs made up more than a third ($2.51 billion) of these deals. Give your business an edge with our leading industry insights.

Communication

The FDA Law Blog

JULY 10, 2025

These particular CRLs were issued in response to original and supplemental drug and biological product applications submitted to the Agency between 2020 and 2024 that ultimately gained approval. 355(l) ) requires that action packages (which include CRLs, if issued) for approved original NDAs and BLAs (i.e.,

FDA

Pharmaceutical Technology

AUGUST 8, 2025

In 2020, Mylan merged with Upjohn, Pfizer’s off-patent medicine division, to form Viatris. Find out more Mylan has since faced criticism for inflating the price of EpiPen and constraining patient access. The company has faced numerous lawsuits over the years in relation to overcharging drug wholesalers for access.

Packaging

Drug Topics

JUNE 25, 2025

The properties of thimerosal were documented to contribute to the safe use of multidose vials and packaging of vaccines, such as seasonal and pandemic influenza vaccines. Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products since the 1930s. Thimerosal and Vaccines.

Vaccines

Pharmaceutical Technology

JUNE 9, 2025

The European average time between market authorisation and patient access between 2020 and 2024 was defined according to the time (in days) between approval and pricing as well as the time (in days) between approval and reimbursement. These three markets have seen time to reimbursement increase by 83%, 27%, and 32%, respectively, since 2020.

Communication

The Thyroid Pharmacist

MARCH 7, 2025

10] Its not only found in obvious sources like plastic containers and packaging, but also in the lining of canned foods and drinks, receipts, toys, electronics, and household items. When grocery shopping, try to purchase items that are packaged in glass and canned foods that are packaged with BPA-free lining. May 5, 2020.

Health and Personal Care Stores

Pharmaceutical Technology

JULY 11, 2025

In a move towards transparency, the US Food and Drug Administration (FDA) has published more than 200 archived complete response letters (CRLs), which detail reasons for non-approval of drug applications submitted between 2020 and 2024. How will RFK Jr’s American dream for vaccines play out?

FDA

The Checkup by Singlecare

JULY 3, 2025

The Wegovy package insert says 4% of people taking Wegovy during clinical trials reported anxiety as a side effect. A 2020 study linked dopamine in the midbrain to heightened levels of anxiety, and an earlier MIT study found that a dopamine imbalance caused more paranoid behavior in rats.

Insurance

Pharmaceutical Technology

AUGUST 8, 2025

AbbVie and Genmab partnered on the development of Epkinly in 2020. The therapy is a bispecific antibody that targets CD3 and CD20, redirecting and activating T-cells to CD20-expressing cancer B-cells. Give your business an edge with our leading industry insights.

Packaging

Roots Analysis

JANUARY 27, 2025

As can be observed in the figure, the highest number of subcutaneous biologics were approved between 2011 and 2020. It is important to note that, for the purpose of subcutaneous biologics market analysis, the biologics were segregated into antibodies , nucleotides, proteins and vaccines.

Hospitals

Pharmaceutical Technology

JULY 2, 2025

Since 2008, the Association of Chemistry and Pharmacy of Uruguay has played an active role in promoting a National Health Surveillance Agency, and in 2020 the government attempted to launch a similar agency but it ultimately failed. How will RFK Jr’s American dream for vaccines play out?

Packaging

Pharmaceutical Technology

JULY 16, 2025

Blenrep originally won FDA approval in 2020 to treat multiple myeloma. How will RFK Jr’s American dream for vaccines play out? The drugmaker is also seeking a positive decision for the antibody-drug conjugate (ADC) used in combo with Bristol Myers Squibb’s Pomalyst and dexamethasone in the same proposed patient group.

Documentation

Pharmaceutical Technology

JUNE 11, 2025

Founded in 2020, Scorpion raised $420m in the next five years while partnering with several pharmaceutical firms and producing six development candidates, three of which are now undergoing clinical trials. Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JULY 15, 2025

Licensing deals between US and Chinese biopharma companies hit record highs last year, a 280% increase from 2020, according to analysis by GlobalData. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging

Pharmaceutical Technology

JUNE 16, 2025

Following a 2020 agreement, Biogen has the exclusive licence to develop and commercialise Zurzuvae outside the US, excluding Japan, Taiwan, and South Korea. The acquisition affords Supernus a dominant position in the market. Co-developed with Biogen, Zurzuvae earned Sage $36.1m in sales in 2024 and $13.8m in Q1 2025.

Communication

PharmTech

JULY 11, 2025

These letters provide detailed reasons why an application could not be approved in its submitted form, including issues related to safety, efficacy, manufacturing deficiencies, and bioequivalence (1).

FDA

Pharmaceutical Technology

JUNE 13, 2025

Licensing deals between US and Chinese biopharma companies hit record highs last year, up 280% from 2020, according to analysis by GlobalData. Across big pharma, transactions rose 66% from $16.6bn in 2023 to $41.5bn in 2024, demonstrating that China is still the go-to place to discover pipeline candidates.

Communication

Pharmaceutical Technology

JULY 18, 2025

By GlobalData Learn more about Strategic Intelligence Blenrep was approved under the FDA accelerated approval process in 2020 to treat multiple myeloma (MM). How will RFK Jr’s American dream for vaccines play out? Stay proactive with real-time data and expert analysis. Give your business an edge with our leading industry insights.

FDA

Pharmaceutical Technology

JULY 10, 2025

This growth is projected to continue, with GlobalData estimating the market will achieve a value of $40bn by 2020. How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E. In 2011, the market was worth an estimated $50m.

Communication

Pharmaceutical Technology

AUGUST 1, 2025

Citi analysts concurred, writing in a research note that it “misses the superiority scenario that many investors had hoped for” Comparisons are expected to Novo Nordisk’s Ozempic (semaglutide), which underwent a similar trial before winning US Food and Drug Administration (FDA ) approval in reducing MACE in 2020.

Packaging

Pharmaceutical Technology

AUGUST 7, 2025

mRNA technology was accelerated in 2020 due to the modality being central to all Covid vaccinations. According to a report from GlobalData , parent company of Pharmaceutical Technology , the value of mRNA licensing deals held 800% more value in 2024 than in 2019. Give your business an edge with our leading industry insights.

Vaccines

PharmTech

JULY 14, 2025

Thornhill, Ontario, Canada - October 31, 2020: LEO Pharma Canada sign outside their head office building in Thornhill, Ontario, Canada. LEO Pharma AS is a multinational Danish pharmaceutical company | Image Credit: © JHVEPhoto - stock.adobe.com.

Dosage

European Pharmaceutical Review

APRIL 8, 2025

Given that multiple work packages may often start or end together, or else take longer than others ( Figure 1 ), the introduction of new PAT requires assessment and planning by multiple departments. Figure 1 : Process analytical technology implementation in (bio)pharmaceutical GMP manufacturing. References 1. Bliesner DM.

Documentation

European Pharmaceutical Review

APRIL 2, 2025

AI-based optic systems, for example, can enhance defect screening in manufacturing by scanning for packaging defects. 2020; 11(1): 233. 2020; 13: 100114. AI is playing an increasing role in sustainable development 15 and green chemistry by optimizing chemical processes to minimize environmental impact. cited 2025Feb].

FDA

Pharma Mirror

OCTOBER 1, 2020

Since the in-person PACK EXPO International and Healthcare Packaging EXPO have been cancelled, the process and packaging technology specialist Syntegon is presenting its latest solutions at the virtually-hosted PACK EXPO Connects from November 9 to 13, 2020.

Packaging

STAT

JUNE 4, 2024

In theory, they’re supposed to power a basic pain management device she ordered from a company called Zynex Medical in 2020. But a year ago, Zynex informed her that the Tufts plan had never paid, and instead, those bubble-wrapped packages were going to cost her almost $1,000. Continue to STAT+ to read the full story…

Packaging

Roots Analysis

APRIL 20, 2022

This continuously growing pipeline of pharmaceutical drug products has inadvertently led to an increase in the demand for their associated primary packaging and Secondary Packaging solutions. . 3] Some of the advantages offered by pharmaceutical secondary packaging have been depicted below. Company Competitiveness Analysis.

Packaging

pharmaphorum

AUGUST 24, 2020

What current topic will you be addressing in your presentation, and what would you say makes it relevant to 2020? “We 23 rd -24 th November 2020. For exclusive tailored sponsorship packages contact: Alia Malick on +44 (0)20 7827 6168 or email amalick@smi-online.co.uk. Ophthalmic Drugs Conference. OphthalmicDrugs.

Packaging

European Pharmaceutical Review

AUGUST 19, 2022

The market was valued at approximately $100 billion in 2020. According to the report, the packaging segment of the market will be worth $15.6 billion by 2026, as contract manufacturing organisations increasingly adopt newer and efficient ways to package products, increasing demand for new machinery. billion by 2026.

Packaging

European Pharmaceutical Review

AUGUST 23, 2022

A study of the causes of warning letters issued by the US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiological Health (CDRH) between 2010 and 2020 revealed that poor current good manufacturing practice (cGMP) compliance and misbranding were the most common citations.

FDA

pharmaphorum

NOVEMBER 24, 2020

It will have pro forma 2020 revenues of around $115 million, rising to $194 million next year, coming from established contracts with health providers, insurers and payors from all 50 states in the US as well as nine international markets, according to the prospectus for the merger.

Packaging